Search for Clinical Trial Results
Fabry Disease - 32 Studies Found
Status | Study |
Terminated |
Study Name: A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease Condition: Fabry Disease Date: 2013-04-11 Interventions: Drug: Iohexol Evaluations of renal and cardiac function are standard-of-care in young patients with Fabr |
Recruiting |
Study Name: Home Therapy With Replagal in Fabry Disease Condition: Fabry Disease Date: 2011-05-16 |
Recruiting |
Study Name: Fabry Disease Registry Condition: Fabry Disease Date: 2005-09-13 |
Completed |
Study Name: Study to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry Disease Condition: Fabry Disease Date: 2010-10-06 Interventions:
|
Completed |
Study Name: A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease Condition: Fabry Disease Date: 2005-08-30 Interventions: Drug: Agalsidase beta Other Name: Fabrazyme® |
Recruiting |
Study Name: Canadian Fabry Disease Initiative (CFDI) Enzyme Replacement Therapy (ERT) Study Condition: Fabry Disease Date: 2007-03-30 Interventions:
|
Recruiting |
Study Name: Evaluation of the Gastrointestinal Manifestation of Fabry's Disease Condition: Fabry's Disease Date: 2016-06-03 Interventions:
|
Completed |
Study Name: Establishment of Biomarkers for Fabry Disease Condition: Fabry Disease Date: 2010-07-16 Interventions: Other: Fluorescein angiography Fluorescein angiography once every 6 months for 3 years |
Completed |
Study Name: Drug-Drug Interaction Study Between AT1001 and Agalsidase in Subjects With Fabry Disease Condition: Fabry Disease Date: 2010-09-07 Interventions: Drug: AT1001 Capsules, single dose Other Name: migal |
Completed |
Study Name: Open Label Long-term Safety Study of AT1001 in Patients With Fabry Disease Who Have Completed a Previous AT1001 Study Condition: Fabry Disease Date: 2007-09-05 Interventions: Drug: AT1001 AT1001 |